Charles C. Coombes
AuthID: R-00G-9F9
1
TÃTULO: A phase i dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer Full Text
AUTORES: Coombes, RC; Cardoso, F; Isambert, N; Lesimple, T; Soulie, P; Peraire, C; Fohanno, V; Kornowski, A; Ali, T; Schmid, P;
PUBLICAÇÃO: 2013, FONTE: Breast Cancer Research and Treatment, VOLUME: 140, NÚMERO: 1
AUTORES: Coombes, RC; Cardoso, F; Isambert, N; Lesimple, T; Soulie, P; Peraire, C; Fohanno, V; Kornowski, A; Ali, T; Schmid, P;
PUBLICAÇÃO: 2013, FONTE: Breast Cancer Research and Treatment, VOLUME: 140, NÚMERO: 1
INDEXADO EM: 
Scopus 
CrossRef
Scopus CrossRef2
TÃTULO: The transcription factor FOXO3a is a crucial cellular target of gefitinib (Iressa) in breast cancer cells
AUTORES: Janna Krol; Richard E Francis; Andre Albergaria ; Andrew Sunters; Andreas Polychronis; Charles C Coombes; Eric W F Lam;
PUBLICAÇÃO: 2007, FONTE: MOLECULAR CANCER THERAPEUTICS, VOLUME: 6, NÚMERO: 12
AUTORES: Janna Krol; Richard E Francis; Andre Albergaria ; Andrew Sunters; Andreas Polychronis; Charles C Coombes; Eric W F Lam;
PUBLICAÇÃO: 2007, FONTE: MOLECULAR CANCER THERAPEUTICS, VOLUME: 6, NÚMERO: 12
3
TÃTULO: Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG
AUTORES: Nitti, D; Wils, J; Dos Santos, JG; Fountzilas, G; Conte, PF; Sava, C; Tres, A; Coombes, RC; Crivellari, D; Marchet, A; Sanchez, E; Bliss, JM; Homewood, J; Couvreur, ML; Hall, E; Baron, B; Woods, E; Emson, M; Van Cutsem, E; Lise, M;
PUBLICAÇÃO: 2006, FONTE: ANNALS OF ONCOLOGY, VOLUME: 17, NÚMERO: 2
AUTORES: Nitti, D; Wils, J; Dos Santos, JG; Fountzilas, G; Conte, PF; Sava, C; Tres, A; Coombes, RC; Crivellari, D; Marchet, A; Sanchez, E; Bliss, JM; Homewood, J; Couvreur, ML; Hall, E; Baron, B; Woods, E; Emson, M; Van Cutsem, E; Lise, M;
PUBLICAÇÃO: 2006, FONTE: ANNALS OF ONCOLOGY, VOLUME: 17, NÚMERO: 2
